Global Rapid Acting Insulins Market Size, Status and Forecast 2024-2031

Report ID: 934852 | Published Date: Oct 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rapid Acting Insulins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Lispro
        1.2.3 Aspart (NovoLog)
        1.2.4 Glulisine (Apidra)
    1.3 Market by Application
        1.3.1 Global Rapid Acting Insulins Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Type 1 Diabetes
        1.3.3 Type 2 Diabetes
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Rapid Acting Insulins Market Perspective (2016-2027)
    2.2 Rapid Acting Insulins Growth Trends by Regions
        2.2.1 Rapid Acting Insulins Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Rapid Acting Insulins Historic Market Share by Regions (2016-2021)
        2.2.3 Rapid Acting Insulins Forecasted Market Size by Regions (2022-2027)
    2.3 Rapid Acting Insulins Industry Dynamic
        2.3.1 Rapid Acting Insulins Market Trends
        2.3.2 Rapid Acting Insulins Market Drivers
        2.3.3 Rapid Acting Insulins Market Challenges
        2.3.4 Rapid Acting Insulins Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Rapid Acting Insulins Players by Revenue
        3.1.1 Global Top Rapid Acting Insulins Players by Revenue (2016-2021)
        3.1.2 Global Rapid Acting Insulins Revenue Market Share by Players (2016-2021)
    3.2 Global Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Rapid Acting Insulins Revenue
    3.4 Global Rapid Acting Insulins Market Concentration Ratio
        3.4.1 Global Rapid Acting Insulins Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rapid Acting Insulins Revenue in 2020
    3.5 Rapid Acting Insulins Key Players Head office and Area Served
    3.6 Key Players Rapid Acting Insulins Product Solution and Service
    3.7 Date of Enter into Rapid Acting Insulins Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Rapid Acting Insulins Breakdown Data by Type
    4.1 Global Rapid Acting Insulins Historic Market Size by Type (2016-2021)
    4.2 Global Rapid Acting Insulins Forecasted Market Size by Type (2022-2027)

5 Rapid Acting Insulins Breakdown Data by Application
    5.1 Global Rapid Acting Insulins Historic Market Size by Application (2016-2021)
    5.2 Global Rapid Acting Insulins Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Rapid Acting Insulins Market Size (2016-2027)
    6.2 North America Rapid Acting Insulins Market Size by Type
        6.2.1 North America Rapid Acting Insulins Market Size by Type (2016-2021)
        6.2.2 North America Rapid Acting Insulins Market Size by Type (2022-2027)
        6.2.3 North America Rapid Acting Insulins Market Size by Type (2016-2027)
    6.3 North America Rapid Acting Insulins Market Size by Application
        6.3.1 North America Rapid Acting Insulins Market Size by Application (2016-2021)
        6.3.2 North America Rapid Acting Insulins Market Size by Application (2022-2027)
        6.3.3 North America Rapid Acting Insulins Market Size by Application (2016-2027)
    6.4 North America Rapid Acting Insulins Market Size by Country
        6.4.1 North America Rapid Acting Insulins Market Size by Country (2016-2021)
        6.4.2 North America Rapid Acting Insulins Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Rapid Acting Insulins Market Size (2016-2027)
    7.2 Europe Rapid Acting Insulins Market Size by Type
        7.2.1 Europe Rapid Acting Insulins Market Size by Type (2016-2021)
        7.2.2 Europe Rapid Acting Insulins Market Size by Type (2022-2027)
        7.2.3 Europe Rapid Acting Insulins Market Size by Type (2016-2027)
    7.3 Europe Rapid Acting Insulins Market Size by Application
        7.3.1 Europe Rapid Acting Insulins Market Size by Application (2016-2021)
        7.3.2 Europe Rapid Acting Insulins Market Size by Application (2022-2027)
        7.3.3 Europe Rapid Acting Insulins Market Size by Application (2016-2027)
    7.4 Europe Rapid Acting Insulins Market Size by Country
        7.4.1 Europe Rapid Acting Insulins Market Size by Country (2016-2021)
        7.4.2 Europe Rapid Acting Insulins Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Rapid Acting Insulins Market Size (2016-2027)
    8.2 Asia-Pacific Rapid Acting Insulins Market Size by Type
        8.2.1 Asia-Pacific Rapid Acting Insulins Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Rapid Acting Insulins Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Rapid Acting Insulins Market Size by Type (2016-2027)
    8.3 Asia-Pacific Rapid Acting Insulins Market Size by Application
        8.3.1 Asia-Pacific Rapid Acting Insulins Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Rapid Acting Insulins Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Rapid Acting Insulins Market Size by Application (2016-2027)
    8.4 Asia-Pacific Rapid Acting Insulins Market Size by Region
        8.4.1 Asia-Pacific Rapid Acting Insulins Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Rapid Acting Insulins Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Rapid Acting Insulins Market Size (2016-2027)
    9.2 Latin America Rapid Acting Insulins Market Size by Type
        9.2.1 Latin America Rapid Acting Insulins Market Size by Type (2016-2021)
        9.2.2 Latin America Rapid Acting Insulins Market Size by Type (2022-2027)
        9.2.3 Latin America Rapid Acting Insulins Market Size by Type (2016-2027)
    9.3 Latin America Rapid Acting Insulins Market Size by Application
        9.3.1 Latin America Rapid Acting Insulins Market Size by Application (2016-2021)
        9.3.2 Latin America Rapid Acting Insulins Market Size by Application (2022-2027)
        9.3.3 Latin America Rapid Acting Insulins Market Size by Application (2016-2027)
    9.4 Latin America Rapid Acting Insulins Market Size by Country
        9.4.1 Latin America Rapid Acting Insulins Market Size by Country (2016-2021)
        9.4.2 Latin America Rapid Acting Insulins Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Rapid Acting Insulins Market Size (2016-2027)
    10.2 Middle East & Africa Rapid Acting Insulins Market Size by Type
        10.2.1 Middle East & Africa Rapid Acting Insulins Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Rapid Acting Insulins Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Rapid Acting Insulins Market Size by Type (2016-2027)
    10.3 Middle East & Africa Rapid Acting Insulins Market Size by Application
        10.3.1 Middle East & Africa Rapid Acting Insulins Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Rapid Acting Insulins Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Rapid Acting Insulins Market Size by Application (2016-2027)
    10.4 Middle East & Africa Rapid Acting Insulins Market Size by Country
        10.4.1 Middle East & Africa Rapid Acting Insulins Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Rapid Acting Insulins Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Details
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Rapid Acting Insulins Introduction
        11.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2016-2021)
        11.1.5 Eli Lilly Recent Development
    11.2 Novo Nordisk
        11.2.1 Novo Nordisk Company Details
        11.2.2 Novo Nordisk Business Overview
        11.2.3 Novo Nordisk Rapid Acting Insulins Introduction
        11.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2016-2021)
        11.2.5 Novo Nordisk Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Rapid Acting Insulins Introduction
        11.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2016-2021)
        11.3.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Rapid Acting Insulins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Lispro
    Table 3. Key Players of Aspart (NovoLog)
    Table 4. Key Players of Glulisine (Apidra)
    Table 5. Global Rapid Acting Insulins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Rapid Acting Insulins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Rapid Acting Insulins Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Rapid Acting Insulins Market Share by Regions (2016-2021)
    Table 9. Global Rapid Acting Insulins Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Rapid Acting Insulins Market Share by Regions (2022-2027)
    Table 11. Rapid Acting Insulins Market Trends
    Table 12. Rapid Acting Insulins Market Drivers
    Table 13. Rapid Acting Insulins Market Challenges
    Table 14. Rapid Acting Insulins Market Restraints
    Table 15. Global Rapid Acting Insulins Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Rapid Acting Insulins Market Share by Players (2016-2021)
    Table 17. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Acting Insulins as of 2020)
    Table 18. Ranking of Global Top Rapid Acting Insulins Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Rapid Acting Insulins Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Rapid Acting Insulins Product Solution and Service
    Table 22. Date of Enter into Rapid Acting Insulins Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Rapid Acting Insulins Revenue Market Share by Type (2016-2021)
    Table 26. Global Rapid Acting Insulins Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Rapid Acting Insulins Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Rapid Acting Insulins Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Rapid Acting Insulins Revenue Market Share by Application (2016-2021)
    Table 30. Global Rapid Acting Insulins Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Rapid Acting Insulins Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Rapid Acting Insulins Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Rapid Acting Insulins Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Eli Lilly Company Details
    Table 63. Eli Lilly Business Overview
    Table 64. Eli Lilly Rapid Acting Insulins Product
    Table 65. Eli Lilly Revenue in Rapid Acting Insulins Business (2016-2021) & (US$ Million)
    Table 66. Eli Lilly Recent Development
    Table 67. Novo Nordisk Company Details
    Table 68. Novo Nordisk Business Overview
    Table 69. Novo Nordisk Rapid Acting Insulins Product
    Table 70. Novo Nordisk Revenue in Rapid Acting Insulins Business (2016-2021) & (US$ Million)
    Table 71. Novo Nordisk Recent Development
    Table 72. Sanofi Company Details
    Table 73. Sanofi Business Overview
    Table 74. Sanofi Rapid Acting Insulins Product
    Table 75. Sanofi Revenue in Rapid Acting Insulins Business (2016-2021) & (US$ Million)
    Table 76. Sanofi Recent Development
    Table 77. Research Programs/Design for This Report
    Table 78. Key Data Information from Secondary Sources
    Table 79. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rapid Acting Insulins Market Share by Type: 2020 VS 2027
    Figure 2. Lispro Features
    Figure 3. Aspart (NovoLog) Features
    Figure 4. Glulisine (Apidra) Features
    Figure 5. Global Rapid Acting Insulins Market Share by Application: 2020 VS 2027
    Figure 6. Type 1 Diabetes Case Studies
    Figure 7. Type 2 Diabetes Case Studies
    Figure 8. Rapid Acting Insulins Report Years Considered
    Figure 9. Global Rapid Acting Insulins Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Rapid Acting Insulins Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Rapid Acting Insulins Market Share by Regions: 2020 VS 2027
    Figure 12. Global Rapid Acting Insulins Market Share by Regions (2022-2027)
    Figure 13. Global Rapid Acting Insulins Market Share by Players in 2020
    Figure 14. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Acting Insulins as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Rapid Acting Insulins Revenue in 2020
    Figure 16. Global Rapid Acting Insulins Revenue Market Share by Type (2016-2021)
    Figure 17. Global Rapid Acting Insulins Revenue Market Share by Type (2022-2027)
    Figure 18. North America Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Rapid Acting Insulins Market Share by Type (2016-2027)
    Figure 20. North America Rapid Acting Insulins Market Share by Application (2016-2027)
    Figure 21. North America Rapid Acting Insulins Market Share by Country (2016-2027)
    Figure 22. United States Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Rapid Acting Insulins Market Share by Type (2016-2027)
    Figure 26. Europe Rapid Acting Insulins Market Share by Application (2016-2027)
    Figure 27. Europe Rapid Acting Insulins Market Share by Country (2016-2027)
    Figure 28. Germany Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Rapid Acting Insulins Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Rapid Acting Insulins Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Rapid Acting Insulins Market Share by Region (2016-2027)
    Figure 38. China Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Rapid Acting Insulins Market Share by Type (2016-2027)
    Figure 46. Latin America Rapid Acting Insulins Market Share by Application (2016-2027)
    Figure 47. Latin America Rapid Acting Insulins Market Share by Country (2016-2027)
    Figure 48. Mexico Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Rapid Acting Insulins Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Rapid Acting Insulins Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Rapid Acting Insulins Market Share by Country (2016-2027)
    Figure 54. Turkey Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Eli Lilly Revenue Growth Rate in Rapid Acting Insulins Business (2016-2021)
    Figure 58. Novo Nordisk Revenue Growth Rate in Rapid Acting Insulins Business (2016-2021)
    Figure 59. Sanofi Revenue Growth Rate in Rapid Acting Insulins Business (2016-2021)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Novo Nordisk
Sanofi
Frequently Asked Questions
Rapid Acting Insulins report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rapid Acting Insulins report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rapid Acting Insulins report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Long Acting Insulins

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for a ... Read More

Premix Insulin

Premix Insulin is a combination of two insulins mixed together: one insulin that is short-acting  ... Read More

Animal Insulin

Animal insulin is derived from cows and pigs. Animal insulin was the first type of insulin to be  ... Read More